Navigation Links
Today's Technical View: AstraZeneca, GlaxoSmithKline, Keryx Biopharma, and Raptor Pharma
Date:7/11/2013

y covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  • For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

  • COMPLIANCE PROCEDURE

    Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

    NOT FINANCIAL ADVICE

    Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

    NO WARRANTY OR LIABILITY ASSUMED

    Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network express
    '/>"/>

    SOURCE AAA Research Reports
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma
    2. Todays Technical View: Elan Corp., Amarin, Seattle Genetics, and Cubist Pharma
    3. Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review
    4. BC Technical Acquires MEDX
    5. Call for Papers for Pittcon 2014 Technical Program
    6. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
    7. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
    8. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Book Titles Until the End of March at Chemical Publishing Company
    9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
    10. Technical Analysis on GNC Holdings and Walgreen: Drug Store Stocks Set to Provide Good Returns
    11. New England Biolabs New Website Adds Technical Information, Easy Ordering, and Better Search
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... ... September 02, 2015 , ... The wet form ... of special anti-vascular endothelial growth factor agents given by injection into the eye. ... have a scientific protocol for the many millions diagnosed with it. AMD usually ...
    (Date:9/2/2015)... DUBLIN , Sep. 02, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/bvxxkf/cytogenetics ) has announced the addition ... - Technologies, Markets and Companies" to ... cytogenetics includes several technologies besides fluorescence in ... and multicolor FISH. Molecular cytogenetics includes application ...
    (Date:9/2/2015)... 2, 2015  Neurotech Pharmaceuticals, Inc., announced today ... multicenter Phase 2 clinical trial of NT-503 Encapsulated ... recurrent subfoveal choroidal neovascularization secondary to age related ... vascular endothelial growth factor (VEGF) receptor protein continuously ... "This landmark proof-of-concept study will evaluate NT-503 ECT ...
    (Date:9/2/2015)... , Sept. 2, 2015 Veracyte, Inc. (NASDAQ: ... Anderson , president and chief executive officer, will present ... September 16, 2015 at 10:30 a.m. ET in ... The live audio webcast and subsequent replay may be ... will be available shortly after conclusion of the presentation ...
    Breaking Biology Technology:StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Veracyte to Present at Morgan Stanley Global Healthcare Conference 2
    ... have developed a method for culturing mammalian neurons in chambers ... extends the lifespan of the neurons at very low densities, ... growth and behavior of individual brain cells. , The technique ... Society of Chemistry Lab on a Chip. , This ...
    ... Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) will be presenting ... at 2:30 p.m. ET in New York, at,the Thomas ... a.m. ET in Boston and at the Bear Stearns ... ET in New York. Daniel M. Bradbury,President and Chief ...
    ... New company offers innovative casting, splinting and ... 31 Enova Medical Technologies,Inc. of St. ... of Aspen,Colo., are pleased to announce the ... that will develop and commercialize innovative orthopedic,support ...
    Cached Biology Technology:Microfluidic chambers advance the science of growing neurons 2Microfluidic chambers advance the science of growing neurons 3Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference 2Enova Medical Launches Exos Corporation 2
    (Date:8/19/2015)... 2015  VOXX International Corporation (Nasdaq: VOXX ... a Definitive Agreement to purchase the assets, inclusive ... leader EyeLock through an acquiring entity.  Upon consummation ... interest in the acquiring entity. The closing of ... diligence.  Expanding on its existing supply chain and ...
    (Date:8/18/2015)... Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ) ... Biometric Authentication & Identification Market: Focus On Modality, ... report to their offering. ... is expected to grow at an estimated CAGR ... over $25 billion (approximately) by 2020 as per ...
    (Date:8/12/2015)... Minn. , Aug. 12, 2015   MedNet ... supports the entire spectrum of clinical research, is proud ... , the company,s comprehensive SaaS-based eClinical technology platform, has ... during the first two quarters of 2015.   Q2 ... second largest quarters measured by contract value sold in ...
    Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
    ... Biofuels based on ethanol, vegetable oil and other renewable ... a way to reduce fossil fuel dependence and limit ... a biologist at the University of Washington, Bothell, shows ... might have exactly the opposite impacts than intended. The ...
    ... Clouds have typically posed a problem to scientists using ... where humans live and breathe, because they block the ... Earth,s surface. It turns out, however, that these "obstructions" ... characteristics actually serve a valuable role in Earth,s climate. ...
    ... RELEASE, 26 May 2008] Scientists at the Swedish medical ... that is much cheaper than those currently in use ... make it possible to map disease genes in large ... for new treatments for a wide variety of diseases. ...
    Cached Biology News:Some biofuels might do more harm than good to the environment, study finds 2Some biofuels might do more harm than good to the environment, study finds 3Satellites illuminate pollution's influence on clouds 2Satellites illuminate pollution's influence on clouds 3New cheaper method for mapping disease genes 2
    ... rapid analytical to medium scale affinity purification ... vectors. Sufficient reagents are provided for purification ... under native or denaturing conditions. Crude samples ... retains STag fusion proteins. After unbound proteins ...
    ... AAIPharmas Biotech Solutions Group combines deep experience, ... special qualities of collaborative team chemistry. This ... concept to approval and beyond.,With AAIBiotech, you ... But you get more than that: its ...
    S-100 alpha/beta chain (8B10)...
    ... number is a new product number, ... number. If showing no availability yet, ... number (Z71,487-9) or contact customer service ... neck 100 mm, No. of sidearm ...
    Biology Products: